TSLP in Asthma: Examining the Evidence* | American Thoracic Society

Thank you

This live web event has ended. Thank you for attending.

Description

There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us on October 12th at 6:30p.m. as two experts explore the role of a key epithelial cytokine, thymic stromal lymphopoietin (TSLP), in driving multiple downstream inflammatory pathways.

This program is Sponsored by Amgen/AstraZeneca.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.

Contributors

Geoffrey Chupp

Pulmonologist
Professor of Pulmonary Medicine
Director, Yale Center for Asthma and Airways Disease
Yale School of Medicine
Director, Pulmonary Function Laboratory
Yale-New Haven Hospital

Dr. Geoffrey Chupp is a Professor of Pulmonary Medicine at Yale School of Medicine and the Director of the Pulmonary Function Laboratory at Yale-New Haven Hospital. He is also the Director of the Yale Center for Asthma and Airways Disease, a program he helped develop, which is a multidisciplinary clinical program that focuses on the care of patients with severe asthma and other complicated airway diseases. Dr. Chupp has over 30 years of experience in the medical field and is recognized for his work in respiratory medicine.
David M. Lang, MD

Professor of Medicine, Cleveland Clinic Lerner College of Medicine;
Chair, Department of Allergy and Clinical Immunology, Respiratory Institute, Cleveland Clinic

David Lang received his M.D. from University of Michigan, completed Internal Medicine training at Henry Ford Hospital, Allergy/Immunology fellowship at Scripps Clinic, and Medical Education Fellowship at Cleveland Clinic.
Dr. Lang has carried out a number of research projects, including studies of aspirin exacerbated respiratory disease, asthma, anaphylaxis, drug allergy, and urticaria. He has published numerous articles, chapters, and abstracts. He teaches evidence-based medicine at Cleveland Clinic Lerner College of Medicine.
Dr. Lang served as President of the American Academy of Allergy, Asthma and Immunology from 2019-2020. He has chaired or served on numerous committees/task forces, formerly served as Co-Chair of the Joint Task Force on Practice Parameters, and was a member of this Task Force from 2001-2018. He currently serves on the Primary Care and Chronic Illness Standing Committee at the National Quality Forum, and previously was Co-Chair of the Pulmonary and Critical Care Standing Committee.
Dr. Lang’s medical career has been supported by his wife, Marjory, and children, Madelyn and Jonathan. He appreciates support from family, friends, and colleagues, and is grateful for opportunities to contribute to the field of Allergy/Immunology.

TSLP Inflammation
https://www.tslpinflammation.com/

Thank you

Description

Contributors

Geoffrey Chupp

David M. Lang, MD